tyramine has been researched along with atenolol in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Becker, HJ; Grobecker, H; Lutz, E; Petersen, P; Planz, G; Simrock, R; Wiethold, G | 1 |
| Chiba, S; Furukawa, Y; Karasawa, Y; Murakami, M; Ren, LM; Takayama, S | 1 |
| Johnson, AK; Kirby, RF | 1 |
| Hashimoto, K; Sugiyama, A | 1 |
| Banerjee, AK; De Boer, HJ; Dhasmana, KM; Saxena, PR | 1 |
| Bégué, JM; de Leiris, J; Feuvray, D; Gauduel, Y | 1 |
| Chichorro, JG; Lorenzetti, BB; Zampronio, AR | 1 |
1 review(s) available for tyramine and atenolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for tyramine and atenolol
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Specific and non-specific effects of beta-adreno-receptor blocking drugs in man (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Platelets; Blood Pressure; Catecholamines; Dopamine beta-Hydroxylase; Humans; Physical Exertion; Practolol; Propranolol; Serotonin; Tyramine | 1976 |
Pharmacological analysis of positive chronotropic and inotropic responses to etilefrine in isolated dog heart preparations.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Etilefrine; Heart Rate; Hemodynamics; Imipramine; Myocardial Contraction; Perfusion; Propanolamines; Tyramine | 1992 |
Effects of sympathetic activation on plasma renin activity in the developing rat.
Topics: Age Factors; Animals; Atenolol; Female; Male; Prenalterol; Rats; Rats, Inbred Strains; Renin; Sympathetic Nervous System; Tyramine; Yohimbine | 1990 |
Chronotropic and inotropic effects of kampo extracts in the canine isolated, blood-perfused heart preparations.
Topics: Animals; Atenolol; Coronary Circulation; Dogs; Drugs, Chinese Herbal; Female; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Papillary Muscles; Reserpine; Sinoatrial Node; Tetrodotoxin; Tyramine | 1989 |
Analysis of the tachycardiac response to 5-hydroxytryptamine in the spinal guinea-pig.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Decerebrate State; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Piperidines; Propranolol; Reserpine; Serotonin; Serotonin Antagonists; Tyramine | 1988 |
[Early cellular alterations induced by myocardial hypoxia: possible role of cyclic AMP (author's transl)].
Topics: Adenosine Triphosphate; Animals; Atenolol; Catecholamines; Cyclic AMP; Cyclic GMP; Glycogen; Hypoxia; L-Lactate Dehydrogenase; Male; Myocardium; Perfusion; Phosphocreatine; Rats; Time Factors; Tyramine | 1980 |
Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats.
Topics: Animals; Arachidonic Acids; Atenolol; Behavior, Animal; Biogenic Amines; Bradykinin; Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Captopril; Celecoxib; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Facial Pain; Formaldehyde; Guanethidine; Hindlimb; Indomethacin; Injections, Subcutaneous; Interleukin-6; Interleukin-8; Lip; Male; Meloxicam; Nociceptors; Prostaglandins; Pyrazoles; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Sulfonamides; Thiazines; Thiazoles; Tumor Necrosis Factor-alpha; Tyramine | 2004 |